This respiratory illness season, wearing a mask is required in patient and resident areas at Sunnybrook. Read our visitor guidelines »

Hospital  >  Departments  >  Medicine  >  Divisions  >  Medical Oncology & Hematology  >  Division Summary
PAGE
MENU

Medicine care team

Medical Oncology/ Hematology

Dr Scott Berry, MD, MHSc, FRCPC

Medical Oncologist
Associate Professor, University of Toronto

Odette Cancer Centre
Sunnybrook Health Sciences Centre
2075 Bayview Ave., Room T2-036
Toronto, ON
M4N 3M5


Phone: 416-480-4270
Fax: 416-480-6002

Administrative Assistant: Alisha Grouios
Phone: 416-480-4270
Fax: 416-480-6002
Email: alisha.grouios@sunnybrook.ca

Dr Scott Berry is a medical oncologist at Sunnybrook Odette Cancer Centre and an associate professor in the Faculty of Medicine at the University of Toronto. He completed his general medical training and medical oncology training at the University of Toronto.

Dr. Berry's is an active participant in clinical research at the National Cancer Institute of Canada (NCIC) Clinical Trials Group and the North American Intergroup.  He has been involved in important international trials in colorectal cancer that have been published in journals including the New England Journal of Medicine and the Annals of Oncology.  Dr. Berry has also authored several prostate and colorectal cancer guidelines for the Cancer Care Ontario Program in Evidence Based Care and chaired national consensus guideline meetings for the Colorectal Cancer Association of Canada.

Dr. Berry also loves teaching and education.  He chairs the Royal College of Physicians and Surgeons of Canada Specialty Committee for Medical Oncology.  He is the Program Director for the Medical Oncology Training Program at the University of Toronto and co-medical director of www.oncologyeducation.com

His other academic interest is the bioethical issues surrounding the care of people with cancer, in particular the ethical issues surrounding funding new and expensive cancer medications.  Dr. Berry has a Masters degree in bioethics from the University of Toronto.  He is the ethics advisor to the pan-Canadian Oncology Drug Review and the NCIC Data Safety Monitoring Committee and a member of the ASCO Ethics Committee.

Appointments and Affiliations:

  • Affiliate scientist, evaluative clinical sciences - Odette cancer research program, Sunnybrook Research Institute
  • Program director, University of Toronto medical oncology training program
  • Medical oncologist - Odette Cancer Centre
  • Gastrointestinal cancer disease site leader, Odette Cancer Centre
  • Associate professor, department of medicine - University of Toronto
  • Specialty committee chair, Royal College of Physicians and Surgeons of Canada